Moderna jumps 40% after trial results; Merck, BioNTech rise
Moderna is squeezing, now up 40%, while Merck rises 3.4% and BioNTech 3.9% after trial results, with no further catalyst supplied.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.